沃华医药
(002107)
| 流通市值：42.00亿 | | | 总市值：42.42亿 |
| 流通股本：5.71亿 | | | 总股本：5.77亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 588,844,408.64 | 393,349,512.77 | 219,045,381.55 | 816,952,424.84 |
| 营业总成本 | 481,393,835.28 | 315,038,296 | 177,276,991.23 | 721,298,250.06 |
| 其他经营收益 | | | | |
| 营业利润 | 109,973,629.9 | 80,710,060.22 | 43,522,680.43 | 103,598,043.94 |
| 利润总额 | 110,299,477 | 81,101,316.15 | 43,891,565.18 | 102,379,572.89 |
| 净利润 | 97,495,338.6 | 71,033,118.92 | 38,450,878.36 | 88,791,071.62 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 97,495,338.6 | 71,033,118.92 | 38,450,878.36 | 88,791,071.62 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 528,153,674.86 | 559,798,896.26 | 539,479,237.17 | 566,770,936.67 |
| 非流动资产: | | | | |
| 非流动资产合计 | 388,194,136.21 | 395,798,845.23 | 403,160,722.74 | 410,599,030.53 |
| 资产总计 | 916,347,811.07 | 955,597,741.49 | 942,639,959.91 | 977,369,967.2 |
| 流动负债: | | | | |
| 流动负债合计 | 239,666,858.25 | 237,076,365.13 | 256,280,232.63 | 240,731,078.72 |
| 非流动负债: | | | | |
| 非流动负债合计 | 13,619,644.97 | 14,388,764.99 | 14,809,356.46 | 15,738,794.43 |
| 负债合计 | 253,286,503.22 | 251,465,130.12 | 271,089,589.09 | 256,469,873.15 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 664,666,836.19 | 707,112,139.6 | 676,194,581.49 | 723,818,446.05 |
| 股东权益合计 | 663,061,307.85 | 704,132,611.37 | 671,550,370.82 | 720,900,094.05 |
| 负债和股东权益合计 | 916,347,811.07 | 955,597,741.49 | 942,639,959.91 | 977,369,967.2 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 666,710,319.46 | 454,230,641.4 | 256,981,306.76 | 920,068,558.07 |
| 经营活动现金流出小计 | 545,370,555.78 | 372,863,138.92 | 189,337,935.55 | 791,542,942.07 |
| 经营活动产生的现金流量净额 | 121,339,763.68 | 81,367,502.48 | 67,643,371.21 | 128,525,616 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | - | - | - | 15,473,572 |
| 投资活动现金流出小计 | 1,421,860.97 | 1,095,065.21 | 717,575.21 | 864,503.16 |
| 投资活动产生的现金流量净额 | -1,421,860.97 | -1,095,065.21 | -717,575.21 | 14,609,068.84 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 150,833,281.76 | 88,184,286.48 | 87,901,689.93 | 91,973,084.68 |
| 筹资活动产生的现金流量净额 | -150,833,281.76 | -88,184,286.48 | -87,901,689.93 | -91,973,084.68 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -30,915,379.05 | -7,911,849.21 | -20,975,893.93 | 51,161,600.16 |
| 期末现金及现金等价物余额 | 363,122,427.01 | 386,125,956.85 | 373,061,912.13 | 394,037,806.06 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -7,911,849.21 | - | 51,161,600.16 |